HER2 expression status in diverse cancers: review of results from 37,992 patients

Human epidermal growth factor receptor 2 (HER2) amplification/overexpression is an effective therapeutic target in breast and gastric cancer. Although HER2 positivity has been reported in other malignancies, previous studies generally focused on one cancer type, making it challenging to compare HER2...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Min, Schwaederle, Maria, Arguello, David, Millis, Sherri Z., Gatalica, Zoran, Kurzrock, Razelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2015
Materias:
Clinical
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4368842/
https://www.ncbi.nlm.nih.gov/pubmed/25712293
http://dx.doi.org/10.1007/s10555-015-9552-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4368842/
https://www.ncbi.nlm.nih.gov/pubmed/25712293
http://dx.doi.org/10.1007/s10555-015-9552-6

Ejemplares similares